BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Laser capture microdissection
,
Rapamycin
,
rs2476601
,
BRCA1
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Mek1 2
Summary
General Info
Curated Studies
Most Correlated Studies
Melanoma Me13 cells treated with MEK1/2, PI3K/mTOR, mTOR, and BRAF V600E inhibitors
SK-MEL-28 melanoma cells with anthrax lethal toxin-induced knockdown of MEK1 and MEK2
Lung cancer A549 and Calu-6 cells treated with pimasertib
Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
Colorectal cancer organoids derived from patients and treated with trametinib and PRI-724
Explore Curated Studies Results
Literature
Most Relevant Literature
Role of Superoxide Reductase FA796 in Oxidative Stress Resistance in Filifactor alocis.
The disruption of the MAPKK gene triggering the synthesis of flavonoids in endophytic fungus Phomops…
Genome-wide identification and expression profiling of thes MAPK, MAPKK, and MAPKKK gene families in…
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.
Wide-Ranging Effects of the Yeast Ptc1 Protein Phosphatase Acting Through the MAPK Kinase Mkk1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in…
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF…
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ